Author

Minghao Sun

Institution: Capricor Therapeutics (United States)

Observed institution: Capricor Therapeutics (United States)

ORCID: 0009-0009-1756-6506

Observed ORCID: 0009-0009-1756-6506

OpenAlex ID: A5040972592

Exosome-Based Multivalent Vaccine: Achieving Potent Immunization, Broadened Reactivity, and Strong T-Cell Responses with Nanograms of Proteins

2023 · Mafalda Cacciottolo, Justin B Nice, et al. · Microbiology Spectrum · 38

Nanograms of SARS-CoV-2 spike protein delivered by exosomes induce potent neutralization of both delta and omicron variants

2023 · Mafalda Cacciottolo, Yujia Li, et al. · PLoS ONE · 19

Multivalent Exosome Based Protein Vaccine: A “Mix and Match” Approach to Epidemic Viruses’ Challenges

2025 · Mafalda Cacciottolo, Li-En Hsieh, et al. · Vaccines · 5

Extracellular Vesicles Delivered a Functional ARG1 Enzyme and Restored Its Activity in a Mouse Model of ARG1-D Resulting in Improved Lifespan

2026 · Li-En Hsieh, Mafalda Cacciottolo, et al. · International Journal of Molecular Sciences · 3

StealthX: A Versatile and Potent Exosome-Based Vaccine Platform for the Next Pandemic

2025 · Minghao Sun, Kristi Elliott · Vaccines · 2

A Novel In Vitro Potency Assay Demonstrating the Anti-Fibrotic Mechanism of Action of CDCs in Deramiocel

2025 · Yujia Li, Justin B. Nice, et al. · Biomedicines · 2

3.33eP Delivery of acid α-glucosidase by muscle-targeting extracellular vesicles: a new road for Pompe disease treatment

2026 · Mafalda Cacciottolo, Li-En Hsieh, et al. · Neuromuscular Disorders

Works count: 7

Citation count: 69

H-index: 3

I10-index: 2